We are live on ! Find out more
CCM

Cinctive Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 43.27%
This Fund
S&P 500
This Quarter Est. Return
+12.67%
1 Year Est. Return
+43.27%
3 Year Est. Return
+162.77%
5 Year Est. Return
+210.46%
10 Year Est. Return
AUM
$2.72B
AUM Growth
+$1.18B
Cap. Flow
+$821M
Cap. Flow %
30.22%
Top 10 Hldgs %
18.67%
Holding
570
New
217
Increased
114
Reduced
73
Closed
160

Top Sells

Rank Stock Value
1
FPS
Forgent Power Solutions
FPS
+$31.5M
2
VLO icon
Valero Energy
VLO
+$27.7M
3
CEG icon
Constellation Energy
CEG
+$21.7M
4
NVDA icon
NVIDIA
NVDA
+$19.2M
5
WBD icon
Warner Bros
WBD
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.76%
2 Consumer Discretionary 16.33%
3 Industrials 12.87%
4 Miscellaneous 10.99%
5 Technology 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALNY icon
326
Alnylam Pharmaceuticals
ALNY
$35.6B
$995K 0.04%
+3,305
New +$997K
UWMC icon
327
UWM Holdings
UWMC
$2.33B
$948K 0.03%
+413,948
New +$1.29M
ORCL icon
328
Oracle
ORCL
$452B
$947K 0.03%
+6,462
New +$1.17M
TXG icon
329
10x Genomics
TXG
$8.15B
$922K 0.03%
+24,057
New +$630K
AMT icon
330
American Tower
AMT
$82B
$916K 0.03%
5,597
+3,822
+215% +$688K
Q
331
Qnity Electronics Inc
Q
$25.3B
$904K 0.03%
+5,536
New +$815K
IRTC icon
332
iRhythm Holdings
IRTC
$4.05B
$888K 0.03%
7,467
-490
-6% -$57K
SRPT icon
333
Sarepta Therapeutics
SRPT
$2.35B
$878K 0.03%
+48,855
New +$924K
SLGN icon
334
Silgan Holdings
SLGN
$4.37B
$853K 0.03%
+18,378
New +$734K
AAPL icon
335
Apple
AAPL
$4.69T
$819K 0.03%
+2,832
New +$810K
MSM icon
336
MSC Industrial Direct
MSM
$6.78B
$751K 0.03%
6,315
-31,855
-83% -$3.38M
CVCO icon
337
Cavco Industries
CVCO
$4.36B
$747K 0.03%
+1,216
New +$646K
MDB icon
338
MongoDB
MDB
$29.9B
$745K 0.03%
+2,219
New +$665K
PLD icon
339
Prologis
PLD
$131B
$720K 0.03%
+5,316
New +$754K
FIX icon
340
Comfort Systems
FIX
$56.6B
$715K 0.03%
+361
New +$655K
DK icon
341
Delek US
DK
$4.4B
$711K 0.03%
+13,999
New +$621K
HON icon
342
Honeywell
HON
$66.1B
$703K 0.03%
+3,139
New +$700K
IMCR icon
343
Immunocore
IMCR
$1.86B
$695K 0.03%
+21,904
New +$648K
PII icon
344
Polaris
PII
$3.57B
$694K 0.03%
+10,134
New +$653K
PCTY icon
345
Paylocity
PCTY
$8.08B
$689K 0.03%
+6,590
New +$702K
PNC icon
346
PNC Financial Services
PNC
$98.1B
$673K 0.02%
+2,733
New +$612K
EXPD icon
347
Expeditors International
EXPD
$24.6B
$641K 0.02%
+3,935
New +$609K
PTCT icon
348
PTC Therapeutics
PTCT
$5.79B
$614K 0.02%
+7,524
New +$543K
KEY icon
349
KeyCorp
KEY
$23.7B
$604K 0.02%
26,216
-125,512
-83% -$2.73M
CRWD icon
350
CrowdStrike
CRWD
$218B
$596K 0.02%
+3,124
New +$444K

Similar funds

Cinctive Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Cinctive Capital Management held 570 positions worth $2.72B, up 77% from $1.53B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Cinctive Capital Management deployed $821M of net new capital in Q2 2026, opening 217 new positions and adding to 114 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 175,100 shares worth $52.6M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Valero Energy, an estimated $27.7M trimmed.

  • Cinctive Capital Management's largest Q2 2026 buy was iShares Russell 2000 ETF: 175,100 shares worth $52.6M.
  • Cinctive Capital Management added most to Vistra in Q2 2026, an estimated $38.5M increase.
  • Cinctive Capital Management's biggest Q2 2026 reduction was Valero Energy, cutting an estimated $27.7M.
  • Cinctive Capital Management fully exited Forgent Power Solutions in Q2 2026, selling an estimated $31.5M.
  • Cinctive Capital Management's ten largest holdings make up 19% of its $2.72B portfolio in Q2 2026.
  • Cinctive Capital Management opened 217 new positions and closed 160 in Q2 2026.
  • Cinctive Capital Management's portfolio value rose 77% quarter-over-quarter to $2.72B.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.